MVS
Recognising qualityPraxis

Is a raw material certificate sufficient as proof of quality?

Direct answer

A raw material certificate evidences the tested batch of the raw material, not the filled product. Processing, filling and storage lie in between.

The decisive question is: what does a document refer to?

MVS RedaktionPublished 2026-10-077 min readReviewed on 2026-09-20Reviewed by: Fachliche Prüfung MVS
Back to omega-3 knowledge
On this page

Two documents, two statements

A raw material certificate says: this batch was fine on delivery. A finished-product analysis says: this product was fine at the time of testing.

What to look for in a document

  • Does it refer to the raw material or the finished product?
  • Which parameters were actually measured?
  • Which batch and date are stated?
  • Who carried out the test?

MVS product evidence

Evidence relating to the finished MVS product.

  • MVS product evidenceCOA · checked 2026-09-15

    Finished-product analysis batch MVS-2609

    The source establishes the described relationship to the stated extent.

  • MVS product evidenceLaborbericht · checked 2026-09-15

    Heavy metals analysis, finished product

    The source establishes the described relationship to the stated extent.

  • MVS product evidenceLaborbericht · checked 2026-09-15

    Capsule and material testing

    The source establishes the described relationship to the stated extent.

  • MVS product evidenceLaborbericht · checked 2026-09-15

    Laboratory report oxidation (TOTOX, PV, AV)

    The source establishes the described relationship to the stated extent.

  • MVS product evidenceLaborbericht · checked 2026-09-15

    Dioxins and PCB analysis

    The source establishes the described relationship to the stated extent.

Sources and reference basis

  1. 1

    Finished-product analysis batch MVS-2609

    MVS Pharma · COA · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  2. 2

    Recommendations on omega-3 intake

    MVS Pharma · Fachgesellschaft · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  3. 3

    Heavy metals analysis, finished product

    MVS Pharma · Laborbericht · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  4. 4

    Capsule and material testing

    MVS Pharma · Laborbericht · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  5. 5

    Laboratory report oxidation (TOTOX, PV, AV)

    MVS Pharma · Laborbericht · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  6. 6

    Review: contaminants in fish oil

    MVS Pharma · Systematischer Review · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  7. 7

    EFSA: scientific assessment on omega-3

    MVS Pharma · Regulatorisches Dokument · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  8. 8

    Manufacturer disclosures Zinzino BalanceOil+

    MVS Pharma · Öffentliche Produktseite · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  9. 9

    Retail data Doppelherz Omega-3

    MVS Pharma · Handelsseite · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  10. 10

    Dioxins and PCB analysis

    MVS Pharma · Laborbericht · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  11. 11

    GOED: monograph on oxidation values

    MVS Pharma · Wissenschaftliche Publikation · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  12. 12

    Review: bioavailability of rTG and EE

    MVS Pharma · Systematischer Review · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  13. 13

    Study: oxidation during storage

    MVS Pharma · Wissenschaftliche Publikation · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

  14. 14

    Manufacturer disclosures NORSAN Omega-3 Pure

    MVS Pharma · Öffentliche Produktseite · 2026-09-15

    Note: Relates to the documented batch or the described scope of investigation.

Why this matters in practice

An oil can arrive excellent and still reach oxidation values after processing or filling that nobody documented.

What MVS publishes

MVS relates its proofs to the finished product and states batch, parameters and date.

Transparency & corrections

This article names its source, status and review date. If you find an error you can submit a correction — it is reviewed, never applied automatically.

Author
MVS Redaktion
Scientific review
Fachliche Prüfung MVS
Published
2026-10-07
Last reviewed
2026-09-20
Submit a correction

Continue in the knowledge system